Journal article · 2017 · Open access

Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study

Andrew J. Schumacher, William M. Sikov, Matthew I. Quesenberry, Howard P. Safran, Humera Khurshid, Kristen M. Mitchell, Adam J. Olszewski

PLoS ONE, 12(2), e0172957 · Published 24 February 2017 · DOI 10.1371/journal.pone.0172957

Open PDFView at the publisherCite this paper

In brief

“Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study” is a 2017 journal article by Andrew J. Schumacher and 6 co-authors, published in PLoS ONE. OpenAlex counts 51 citations as of 22 November 2026, which puts it in the top 8% of works published in 2017 by citations. It is open access under a CC BY licence: the full text is free to read at PLoS ONE.

Citations
51
Most cited in
2024 (8)
Field-weighted impact
3.04
References
31
Authors
7

Abstract

BACKGROUND: Informed consent forms (ICFs) for oncology clinical trials have grown increasingly longer and more complex. We evaluated objective understanding of critical components of informed consent among patients enrolling in contemporary trials of conventional or novel biologic/targeted therapies. METHODS: We evaluated ICFs for cancer clinical trials for length and readability, and patients registered on those studies were asked to complete a validated 14-question survey assessing their understanding of key characteristics of the trial. Mean scores were compared in groups defined by trial and patient characteristics. RESULTS: Fifty patients, of whom half participated in trials of immunotherapy or biologic/targeted agents and half in trials of conventional therapy, completed the survey. On average, ICFs for industry-originated trials (N = 9 trials) were significantly longer (P < .0001) and had lower Flesch ease-of-reading scores (P = .003) than investigator-initiated trials (N = 11). At least 80% of patients incorrectly responded to three key questions which addressed the experimental nature of their trial therapy, its purported efficacy and potential risks relative to alternative treatments. The mean objective understanding score was 76.9±8.8, but it was statistically significantly lower for patients who had not completed high school (P = .011). The scores did not differ significantly by type of cancer therapy (P = .12) or trial sponsor (P = .38). CONCLUSIONS: Many participants enrolled on cancer trials had poor understanding of essential elements of their trial. In order to ensure true informed consent, innovative approaches, such as expanded in-person counseling adapted to the patient's education level or cultural characteristics should be evaluated across socio-demographic groups. TRIAL REGISTRATION: Clinicaltrials.gov NCT01772511.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Schumacher, A. J., Sikov, W. M., Quesenberry, M. I., Safran, H. P., Khurshid, H., Mitchell, K. M., & Olszewski, A. J. (2017). Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study. PLoS ONE, 12(2), e0172957. https://doi.org/10.1371/journal.pone.0172957

MLA 9

Schumacher, Andrew J., et al. “Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study.” PLoS ONE, vol. 12, no. 2, 2017, p. e0172957. https://doi.org/10.1371/journal.pone.0172957.

Chicago

Schumacher, Andrew J., William M. Sikov, Matthew I. Quesenberry, Howard P. Safran, Humera Khurshid, Kristen M. Mitchell, and Adam J. Olszewski. 2017. “Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study.” PLoS ONE 12 (2): e0172957. https://doi.org/10.1371/journal.pone.0172957.

Harvard

Schumacher, A. J. et al. (2017) ‘Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study’, PLoS ONE, 12(2), p. e0172957. doi:10.1371/journal.pone.0172957.

IEEE

A. J. Schumacher et al., “Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study,” PLoS ONE, vol. 12, no. 2, p. e0172957, 2017, doi: 10.1371/journal.pone.0172957.

BibTeX

@article{schumacher2017informed,
  title     = {{Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study}},
  author    = {Schumacher, Andrew J. and Sikov, William M. and Quesenberry, Matthew I. and Safran, Howard P. and Khurshid, Humera and Mitchell, Kristen M. and Olszewski, Adam J.},
  journal   = {PLoS ONE},
  year      = {2017},
  volume    = {12},
  number    = {2},
  pages     = {e0172957},
  doi       = {10.1371/journal.pone.0172957},
  url       = {https://doi.org/10.1371/journal.pone.0172957}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201722
201877
201933
202022
202133
202277
202366
202488
202577
202666

Its field-weighted citation impact is 3.04: it has been cited 3.04 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research

  • informed consent
  • cancer clinical trials
  • informed consent forms
  • patient understanding
  • readability
  • trial length
  • immunotherapy trials
  • industry-sponsored trials

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Schumacher, A. J., Sikov, W. M., Quesenberry, M. I., Safran, H. P., Khurshid, H., Mitchell, K. M., & Olszewski, A. J. (2017). Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study. PLoS ONE, 12(2), e0172957. https://doi.org/10.1371/journal.pone.0172957

How many times has this paper been cited?

51 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PLoS ONE: sign in and open the PDF from this page.

Who wrote this paper?

Andrew J. Schumacher, William M. Sikov, Matthew I. Quesenberry, Howard P. Safran, Humera Khurshid, Kristen M. Mitchell, Adam J. Olszewski.

What is the DOI of this paper?

10.1371/journal.pone.0172957, permanently at https://doi.org/10.1371/journal.pone.0172957. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.